The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Simulect



Novartis Europharm LimitedEU/1/98/084/001

Main Information

Trade NameSimulect
Active SubstancesBasiliximab
Dosage FormPowder and solvent for solution for injection/infusion
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/98/084/001

Group Information

ATC CodeL04AC Interleukin inhibitors
L04AC02 basiliximab

Status

License statusAuthorised
Licence Issued09/10/1998
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back